Head-To-Head Contrast: BioCorRx (OTCMKTS:BICX) vs. Concentra Group Holdings Parent (NYSE:CON)

BioCorRx (OTCMKTS:BICX) and Concentra Group Holdings Parent (NYSE:CON) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, valuation and profitability.

Profitability

This table compares BioCorRx and Concentra Group Holdings Parent’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioCorRx	-11,600.00%	N/A	-1,074.47%
Concentra Group Holdings Parent	N/A	N/A	N/A

Valuation & Earnings

This table compares BioCorRx and Concentra Group Holdings Parent”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioCorRx	$90,000.00	42.68	-$3.77 million	($0.52)	-0.58
Concentra Group Holdings Parent	$1.84 billion	1.52	$179.95 million	N/A	N/A

Concentra Group Holdings Parent has higher revenue and earnings than BioCorRx.

Analyst Ratings

This is a breakdown of recent ratings for BioCorRx and Concentra Group Holdings Parent, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioCorRx	0	0	0	0	0.00
Concentra Group Holdings Parent	0	1	7	0	2.88

Concentra Group Holdings Parent has a consensus target price of $28.50, suggesting a potential upside of 30.14%. Given Concentra Group Holdings Parent’s stronger consensus rating and higher possible upside, analysts plainly believe Concentra Group Holdings Parent is more favorable than BioCorRx.

Summary

Concentra Group Holdings Parent beats BioCorRx on 7 of the 8 factors compared between the two stocks.

About BioCorRx

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

About Concentra Group Holdings Parent

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers’ compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.